Videos

Fibi Attia, MD, the infection prevention coordinator at Penn State Milton S. Hersey Medical Center, says that the main challenge for infection preventionists in the COVID-19 pandemic is not knowing who might be carrying the disease.

Ann Marie Pettis, RN, BSN, CIC, FAPIC: “If indeed flu comes at the same time a second wave of COVID comes, that’s going to be difficult-unbelievably difficult because the symptoms obviously are somewhat similar. We’ll be trying to rule both of those things out. It will create more of a risk for a surge, and it will put more taxing on our PPE supplies.”

Rebecca Leach, RN, BSN, MPH, CIC: “Infection preventionists had to work very closely with our supply chain and look at all of our options and really keep track of it. I also think working with lab more closely will be important in the future, to understand testing modalities, understanding our abilities to test and interpreting those tests.”

Kevin Kavangh, MD: “What worries me the most about reopening is that people going to say, ‘Oh, it’s over with’ and not do any sort of protection, whether it’s social distancing, wearing masks, not gathering in crowds. I really think that people will think, ‘Well, we got this beat.’”

Katherine Perez, PharmD: “For patients with COVID-19, I think the jury’s still out as to how we should be using antibiotics in those patients and what the risk of a secondary bacterial infection truly is. And that type of information has not been made available, at least not in huge amounts at this time.”

Jeffrey Rose: “I think the desire to break apart some of the functionality of the hospital and spread it out into other facilities-like oncology centers or ambulatory surgery centers-to reduce the large population at one building, is going to continue to grow. And in addition, if you design them correctly, you can use those facilities for surge capacity.”

Daniel F. Shay, Esq.: “COVID-19 is not the last infectious disease that we’re going to encounter…. I think that there are good reasons to use telemedicine to the extent that you can reduce the risk to healthcare practitioners, healthcare professionals, and also to other patients, and, frankly, the general populace.”

"We have to be comfortable with the fact that we have to reuse PPE for multiple patients. But one of the things they have to remember is those multiple patients all have the same illness. So, it’s not like we’re going to transfer multi-drug resistant organism to the next patient. Because we try not to use the same PPE for those situations."